TMT & Consumer Independent Equity Research Analyst, Obex Capital Research

Aaron Gabin

I have over 20 years’ experience investing in the TMT and Consumer sectors, almost entirely on the buyside. Started at Bernstein covering software in 2001, moved to the buyside at Government of Singapore Investment Corporation (GIC) in 2003, covering hardware, software, and media. 

After getting an MBA at NYU in 2008 and a CFA, I spent 8 years at Coburn Ventures (a market neutral TMT/Consumer hedge fund). In 2015, I joined Deimos Asset Management, a low net multi-strat, where I managed a  TMT/Consumer portfolio.

I've spent the past few years at Obex Capital Management providing independent investment research to TMT and Consumer investors.

TMT & Consumer Independent Equity Research Analyst

Recent IPO Insights: Expensify (Short Candidate)

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

TMT & Consumer Independent Equity Research

Obex Capital Research

“Obex” is Latin for Barriers to Entry. Obex Capital Management’s investment philosophy is driven by an intense focus on which business model’s Barriers to Entry are able to withstand the ever increasing competitive disruption in the TMT and Consumer Sectors.

Equity Bottom-Up

<ul>
<li>Founded in 2010 and named for a combination of “docs” and “proximity”, Doximity is a healthcare-focused professional network with 1.8M physicians in the US (~80%) on the platform. </li>
<li>Doximity’s platform is free for physisicans, it business model is like LinkedIn: advertising and recruiting, and also telehealth.</li>
<li>Highly profitable model with accelerating net revenue retention. 173% in most recent quarter.</li>
</ul>


Founded in 2010 and named for a combination of “docs” and “proximity”, Doximity is a healthcare-focused professional network with 1.8M physicians in the US (~80%) on the platform. 
Doximity’s platform is free for physisicans, it business model is like LinkedIn: advertising and recruiting, and also telehealth.
Highly profitable model with accelerating net revenue retention. 173% in most recent quarter.


Doximity

Recent IPO Insights: Doximity